Ocular Therapeutix plans wet AMD drug filing for late 2026
Go back to Ocular Therapeutix plans wet AMD drug filing for late 2026| (NASDAQ: OCUL) | Delayed: 10.09 +0.66 (7.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.43 | 52 Week High | $14.50 | |||
| Open | $9.51 | 52 Week Low | $4.04 | |||
| Day High | $10.11 | P/E | N/A | |||
| Day Low | $9.41 | EPS | $0.00 | |||
| Volume | 3,418,968 | |||||

